Multisystemic Therapy Improves Asthma Management in High- Risk African American Teens

2014 ◽  
Author(s):  
S. Naar-King ◽  
D. Ellis ◽  
P.S. King ◽  
P. Lam ◽  
P. Cunningham ◽  
...  
Keyword(s):  
African American ◽  
High Risk ◽  
Asthma Management ◽  
Multisystemic Therapy

Multisystemic Therapy for high-risk African American adolescents with asthma: A randomized clinical trial.

2014 ◽  
Vol 82 (3) ◽  
pp. 536-545 ◽  
Author(s):  
Sylvie Naar-King ◽  
Deborah Ellis ◽  
Pamela S. King ◽  
Phebe Lam ◽  
Phillippe Cunningham ◽  
...  
Keyword(s):  
Clinical Trial ◽  
African American ◽  
High Risk ◽  
Randomized Clinical Trial ◽  
African American Adolescents ◽  
Multisystemic Therapy

HIV and STD Prevention for High-Risk, Inner-City, African American Youth

2008 ◽  
Author(s):  
Daniel Romer ◽  
Ralph DiClemente ◽  
Lawrence Brown ◽  
Peter Vanable ◽  
Robert Valois
Keyword(s):  
African American ◽  
High Risk ◽  
Inner City ◽  
African American Youth ◽  
Std Prevention

scholarly journals Understanding low chemoprevention uptake by women at high risk of breast cancer: findings from a qualitative inductive study of women’s risk-reduction experiences

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Tasleem J. Padamsee ◽  
Megan Hils ◽  
Anna Muraveva
Keyword(s):  
Breast Cancer ◽  
African American ◽  
High Risk ◽  
Risk Reduction ◽  
White Women ◽  
Future Research ◽  
Structured Interviews ◽  
Critical Gap ◽  
High Risk Women ◽  
Parent Project

Abstract Background Chemoprevention is one of several methods that have been developed to help high-risk women reduce their risk of breast cancer. Reasons for the low uptake of chemoprevention are poorly understood. This paper seeks a deeper understanding of this phenomenon by drawing on women’s own narratives about their awareness of chemoprevention and their risk-related experiences. Methods This research is based on a parent project that included fifty in-depth, semi-structured interviews with a purposive sample of African American and White women at elevated risk of breast cancer. This specific study draws on the forty-seven interviews conducted with women at high or severe risk of breast cancer, all of whom are eligible to use chemoprevention for breast cancer risk-reduction. Interviews were analyzed using grounded theory methods. Results Forty-five percent of participants, and only 21% of African American participants, were aware of chemoprevention options. Women who had seen specialists were more likely to be aware, particularly if they had ongoing specialist access. Aware and unaware women relied on different types of sources for prevention-related information. Those whose main source of information was a healthcare provider were more likely to know about chemoprevention. Aware women used more nuanced information gathering strategies and worried more about cancer. Women simultaneously considered all risk-reduction options they knew about. Those who knew about chemoprevention but were reluctant to use it felt this way for multiple reasons, having to do with potential side effects, perceived extreme-ness of the intervention, similarity to chemotherapy, unknown information about chemoprevention, and reluctance to take medications in general. Conclusions Lack of chemoprevention awareness is a critical gap in women’s ability to make health-protective choices. Future research in this field must consider complexities in both women’s perspectives on chemoprevention and the reasons they are reluctant to use it.

scholarly journals Iron Metabolism in African American Women in the Second and Third Trimesters of High-Risk Pregnancies

2017 ◽  
Vol 46 (1) ◽  
pp. 148-158 ◽  
Author(s):  
Lauren Welke ◽  
Mary Dawn Koenig ◽  
Jessica L. Thomson ◽  
Elizabeta Nemeth ◽  
Rosemary White-Traut ◽  
...  
Keyword(s):  
African American ◽  
High Risk ◽  
African American Women ◽  
Iron Metabolism ◽  
American Women
Sign in / Sign up

Export Citation Format

Share Document